# Project implementation and scientific completion status

Release 0.2.0 contains 140 assertions, 51 included publication/resource records, 66 cohort/subset/context registry entries and all 30 original assay labels. The release report records recovered sources and corrected evidence. The checklist below distinguishes implemented infrastructure from remaining scientific work; presence of a table is not evidence coverage.

The initial operational protocol, local knowledge base, independent critic cycle, corrections, heuristic prior interface, exports and hash verification are implemented. Exhaustive corpus construction, broad cytokine extraction, full ontology mapping, human adjudication, calibrated quantitative priors and complete multi-omic paths remain unfinished. Assay-platform documentation and authoritative journal metrics are unavailable.

## Original checklist

| Section | Requirement | Status | Evidence or remaining work |
|---|---|---|---|
| A. Governance | Greenfield review | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| A. Governance | Multi-layer mechanistic framework | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| A. Governance | Adversarial reviewer | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| A. Governance | Prior-only versioning | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| A. Governance | Journal modifier | partial coverage / implementation | Bounded proposal implemented and tested; authoritative JCR data unavailable; neutral multiplier. |
| A. Governance | LLM/instruction provenance | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| A. Governance | Expand scope to genomics | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| A. Governance | Expand scope to transcriptomics | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| A. Governance | Expand scope to proteomics | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| A. Governance | Final protocol | implemented for initial release | Operational v0.1.0 plus coverage/release amendment v0.2.0; no claim of external preregistration or human approval. |
| A. Governance | Hash/register protocol | implemented for initial release | SHA-256 registered locally in instruction and release manifests; no external registry. |
| A. Governance | Final adjudication rules | implemented for initial release | Agent correction, contested evidence, propagation and human-pending states explicit. |
| A. Governance | Release policy | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| B. Ontologies/entities | Cytokines/chemokines | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | Genes | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | proteins/isoforms | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | genetic variants | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | regulatory elements | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | immune cells | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | cell states | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | receptor complexes | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | pathways | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | transcription factors | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | cellular processes | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | tissues | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | diseases | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| B. Ontologies/entities | assay vocabularies | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| C. Source registry | Cytokine databases | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| C. Source registry | signaling databases | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| C. Source registry | GWAS sources | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| C. Source registry | QTL sources | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| C. Source registry | transcriptomic atlases | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| C. Source registry | single-cell atlases | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| C. Source registry | proteomic repositories | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| C. Source registry | functional-genomic resources | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| C. Source registry | versions/retrieval dates/hashes | partial coverage / implementation | Actual snapshots hashed and dates retained; unspecified external resource versions remain unavailable. |
| D. Corpus construction | Cytokine search | partial coverage / implementation | Actual discovery queries saved; bounded retrieval and pilot extraction only. |
| D. Corpus construction | genomic search | partial coverage / implementation | Actual discovery queries saved; bounded retrieval and pilot extraction only. |
| D. Corpus construction | transcriptomic search | partial coverage / implementation | Actual discovery queries saved; bounded retrieval and pilot extraction only. |
| D. Corpus construction | proteomic search | partial coverage / implementation | Actual discovery queries saved; bounded retrieval and pilot extraction only. |
| D. Corpus construction | family/entity-specific searches | partial coverage / implementation | Original capped PubMed discovery retained, plus targeted expansion searches with 408 candidate-level decisions; search saturation not established. |
| D. Corpus construction | citation chaining | partial coverage / implementation | Anchor-driven follow-up sources collected; no exhaustive backward/forward citation graph. |
| D. Corpus construction | deduplication | partial coverage / implementation | Known publication-family and duplicate-preprint relations retained; full search corpus unscreened. |
| D. Corpus construction | cohort deduplication | partial coverage / implementation | Known parent/subset relations and conservative unresolved grouping implemented; sample-level overlap incomplete. |
| D. Corpus construction | frozen initial corpus | implemented for initial release | Original 0.1.0 corpus retained; current release has 140 assertions. Corpus selection remains bounded. |
| E. Extraction | genomic associations | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | molecular QTLs | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | regulatory genomic evidence | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | transcript abundance | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | splicing | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | transcriptional programs | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | protein abundance | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | secretion | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | PTMs/phosphorylation | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | source cell → cytokine | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | cytokine → target | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | receptor | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | signaling | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | cellular process | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | context | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | temporal information | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | null/contradictory evidence | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| E. Extraction | exact provenance | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | variant → gene | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | variant → transcript | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | variant → protein | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | transcript → protein | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | protein → signaling | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | signaling → transcript | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | transcript/protein → function | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | genetic modification of cytokine response | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | cell-state-specific integration | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | tissue-specific integration | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| F. Cross-omic integration | temporal compatibility checks | partial coverage / implementation | Represented in the schema, registry or bounded evidence corpus; broader extraction/verification remains. |
| G. Adversarial review | genomic critique | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| G. Adversarial review | causal-gene critique | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| G. Adversarial review | transcriptomic critique | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| G. Adversarial review | proteomic critique | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| G. Adversarial review | cytokine critique | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| G. Adversarial review | cross-omic compatibility critique | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| G. Adversarial review | duplicate-cohort critique | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| G. Adversarial review | network topology critique | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| G. Adversarial review | human adjudication | pending scientific completion | Pending. No agent action has been labeled human review. |
| H. Prior construction | existence priors | partial coverage / implementation | Explicit-hypothesis Beta summaries available for eligible records; heuristic and uncalibrated. |
| H. Prior construction | direction priors | partial coverage / implementation | Separate Dirichlet summaries; null adequacy and individual eligibility enforced; uncalibrated. |
| H. Prior construction | effect-class priors | partial coverage / implementation | Observed categorical directions exported; no magnitude inference. |
| H. Prior construction | magnitude priors | pending scientific completion | Schema/interface present; required quantitative evidence or calibration is unavailable. |
| H. Prior construction | temporal priors | pending scientific completion | Schema/interface present; required quantitative evidence or calibration is unavailable. |
| H. Prior construction | genetic-modifier priors | pending scientific completion | Schema/interface present; required quantitative evidence or calibration is unavailable. |
| H. Prior construction | expression priors | pending scientific completion | Schema/interface present; required quantitative evidence or calibration is unavailable. |
| H. Prior construction | protein-availability priors | pending scientific completion | Schema/interface present; required quantitative evidence or calibration is unavailable. |
| H. Prior construction | human-transportability priors | pending scientific completion | Schema/interface present; required quantitative evidence or calibration is unavailable. |
| H. Prior construction | context-specific priors | partial coverage / implementation | Context annotations retained; quantitative transport calibration unavailable. |
| H. Prior construction | journal-modifier sensitivity analysis | partial coverage / implementation | No-journal results exported; equal to default because authoritative metrics unavailable and weighting disabled. |
| I. Release | entity tables | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| I. Release | genomic evidence tables | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| I. Release | transcriptomic evidence tables | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| I. Release | proteomic evidence tables | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| I. Release | cytokine interaction tables | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| I. Release | integrated multi-omic paths | pending scientific completion | 0 complete paths; 23 candidate joins subjected to context/bridge checks. |
| I. Release | critic findings | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| I. Release | prior tables | partial coverage / implementation | All ten families exported; real changes tracked against the preceding release; unsupported quantitative families remain unavailable. |
| I. Release | source manifest | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| I. Release | provenance manifest | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| I. Release | protocol/instruction manifest | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| I. Release | QC report | implemented for initial release | Implemented and represented in the frozen initial artifacts; does not imply exhaustive biological coverage. |
| I. Release | freeze/hash Release 0.1 | implemented for initial release | Original local release and manifest preserved; archived inputs allow verification after working files change. Whole-review completion not claimed. |

## Release entry points

- Latest research narrative: `reports/RELEASE_0.2.0.md`
- Initial synthesis: `reports/RESEARCH_SYNTHESIS.md`
- Evidence atlas: `releases/0.2.0/EVIDENCE_ATLAS.md`
- Structural and scientific QC: `releases/0.2.0/qc.json`
- Table dictionary: `data/DATA_DICTIONARY.md`
- Reproduction and interpretation: `RUNNING.md`
- Detailed evidence gaps: `releases/0.2.0/coverage_gaps.csv`

No unscreened search result, local registry entry, empty table or inferred complete path is counted as a reviewed biological assertion.
